Contrast-Enhanced Endoscopic Ultrasound Detects Early Therapy Response Following Anti-TNF Therapy in Patients with Ulcerative Colitis.
Mark EllrichmannBerenice SchulteClaudio C ConradStephan SchochJohannes BethgeMarcus SeegerRobert HuberMadita GoebAlexander ArltSusanna NikolausChristoph RoeckenStefan SchreiberPublished in: Journal of Crohn's & colitis (2024)
dCEUS enables the early detection of therapy response in patients with aUC, which serves as a predictive marker for long-term clinical success. Therefore, dCEUS serves as a diagnostic tool for assessing the probability of future therapy success.